miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
17363563 Colorectal cancer - 114500 Cancer Colo-201 cell miRNA downregulation - 22.0 - Cell culture study quantitative PCR
17363563 Glioblastoma multiforme, somatic - 137800 Cancer U-251 cell miRNA downregulation - 25.6 - Cell culture study quantitative PCR
17942673 Duchenne muscular dystrophy - 310200 Muscular muscle miRNA overexpression - 3.89 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) Muscular muscle miRNA overexpression - 3.57 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2A - 253600 Muscular muscle miRNA overexpression - 3.76 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2B - 253601 Muscular muscle miRNA overexpression - 4.48 - Patient study phenotype-control miRNA microarray
17942673 Miyoshi myopathy - 254130 Muscular muscle miRNA overexpression - 2.95 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 13.52 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Dermatomyositis - 0) Muscular muscle miRNA overexpression - 2.66 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Polymyositis - 0) Muscular muscle miRNA overexpression - 2.8 - Patient study phenotype-control miRNA microarray
18042587 Thrombocytopenic purpurea, autoimmune - 188030 Hematological blood miRNA downregulation - 2.27 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA downregulation - 33.3333 - Cell culture study quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 49.33 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 6.25 - Patient study phenotype-phenotype quantitative PCR
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA downregulation - 20.0 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 33.3333 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 2.12766 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 1.66667 - Cell culture study quantitative PCR
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 1.11 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA downregulation - 2.04082 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
18647411 - - hematopoietic stem cell miRNA downregulation - 7.63 - Bioprocess study miRNA microarray
17379065 - - cord blood stem cell miRNA overexpression - - - Bioprocess study miRNA microarray
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 6.66667 - Cell culture study quantitative PCR